MolecuLight Achieves Frost & Sullivan's 2026 Global Company of the Year Award in Wound Imaging
MolecuLight Recognized as Frost & Sullivan’s 2026 Global Company of the Year
In a significant achievement, MolecuLight has been awarded the Frost & Sullivan 2026 Global Company of the Year Award for its innovative contributions to the wound imaging industry. This accolade acknowledges MolecuLight's commitment to advancing objectivity in wound assessment, improving clinical outcomes, and delivering integrated customer support.
CEO Anil Amlani emphasized that this recognition reflects their unwavering dedication to providing clinicians with objective information that enhances patient care. He stated, “By combining clinically validated imaging with practical workflows, training, and ongoing support, we assist treatment teams in translating this information into treatment decisions that drive better healing.
Topics Other）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.